185 related articles for article (PubMed ID: 27402805)
21. A comprehensive population-based characterization of heart failure with mid-range ejection fraction.
Koh AS; Tay WT; Teng THK; Vedin O; Benson L; Dahlstrom U; Savarese G; Lam CSP; Lund LH
Eur J Heart Fail; 2017 Dec; 19(12):1624-1634. PubMed ID: 28948683
[TBL] [Abstract][Full Text] [Related]
22. CRT Efficacy in "Mid-Range" QRS Duration Among Asians Contrasted to Non-Asians, and Influence of Height.
Varma N; Wang JA; Jaswal A; Sethi KK; Kondo Y; Joung B; Yoo D; Auricchio A; Singh JP; Lee K; Gold MR
JACC Clin Electrophysiol; 2022 Feb; 8(2):211-221. PubMed ID: 34838518
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of de novo and acute decompensated heart failure patients according to ejection fraction.
Choi KH; Lee GY; Choi JO; Jeon ES; Lee HY; Cho HJ; Lee SE; Kim MS; Kim JJ; Hwang KK; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Park HY; Cho MC; Oh BH
Heart; 2018 Mar; 104(6):525-532. PubMed ID: 28982721
[TBL] [Abstract][Full Text] [Related]
24. Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
Son MK; Park JJ; Lim NK; Kim WH; Choi DJ
Heart; 2020 Aug; 106(15):1160-1168. PubMed ID: 32341140
[TBL] [Abstract][Full Text] [Related]
25. Impact of Body Mass Index on Heart Failure by Race/Ethnicity From the Get With The Guidelines-Heart Failure (GWTG-HF) Registry.
Powell-Wiley TM; Ngwa J; Kebede S; Lu D; Schulte PJ; Bhatt DL; Yancy C; Fonarow GC; Albert MA
JACC Heart Fail; 2018 Mar; 6(3):233-242. PubMed ID: 29428434
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of, associations with, and prognostic role of anemia in heart failure across the ejection fraction spectrum.
Savarese G; Jonsson Å; Hallberg AC; Dahlström U; Edner M; Lund LH
Int J Cardiol; 2020 Jan; 298():59-65. PubMed ID: 31521440
[TBL] [Abstract][Full Text] [Related]
27. Is mechanical dyssynchrony a therapeutic target in heart failure with preserved ejection fraction?
Menet A; Greffe L; Ennezat PV; Delelis F; Guyomar Y; Castel AL; Guiot A; Graux P; Tribouilloy C; Marechaux S
Am Heart J; 2014 Dec; 168(6):909-16.e1. PubMed ID: 25458655
[TBL] [Abstract][Full Text] [Related]
28. Mortality and readmission risk in relation to QRS duration among patients hospitalized for heart failure with preserved ejection fraction.
Downey M; Gravely A; Westanmo A; Hubers S; Adabag S
J Electrocardiol; 2022; 74():109-113. PubMed ID: 36115266
[TBL] [Abstract][Full Text] [Related]
29. Effect of QRS Morphology and Duration on Clinical Outcomes After Cardiac Resynchronization Therapy - Analysis of Japanese Multicenter Registry.
Oka T; Inoue K; Tanaka K; Hirao Y; Isshiki T; Kimura T; Nobuyoshi M; Shizuta S; Arita T; Fujii S; Iwakura K; Fujii K; Ando K
Circ J; 2018 Jun; 82(7):1813-1821. PubMed ID: 29628460
[TBL] [Abstract][Full Text] [Related]
30. Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy.
Biton Y; Kutyifa V; Cygankiewicz I; Goldenberg I; Klein H; McNitt S; Polonsky B; Ruwald AC; Ruwald MH; Moss AJ; Zareba W
Circ Heart Fail; 2016 Feb; 9(2):e002667. PubMed ID: 26823498
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and incidence of intra-ventricular conduction delays and outcomes in patients with heart failure and reduced ejection fraction: insights from PARADIGM-HF and ATMOSPHERE.
Kristensen SL; Castagno D; Shen L; Jhund PS; Docherty KF; Rørth R; Abraham WT; Desai AS; Dickstein K; Rouleau JL; Zile MR; Swedberg K; Packer M; Solomon SD; Køber L; McMurray JJV;
Eur J Heart Fail; 2020 Dec; 22(12):2370-2379. PubMed ID: 32720404
[TBL] [Abstract][Full Text] [Related]
32. Cardiac resynchronization therapy in women versus men: observational comparative effectiveness study from the National Cardiovascular Data Registry.
Zusterzeel R; Spatz ES; Curtis JP; Sanders WE; Selzman KA; Piña IL; Bao H; Ponirakis A; Varosy PD; Masoudi FA; Caños DA; Strauss DG
Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2 Suppl 1):S4-11. PubMed ID: 25714821
[TBL] [Abstract][Full Text] [Related]
33. Probability and magnitude of response to cardiac resynchronization therapy according to QRS duration and gender in nonischemic cardiomyopathy and LBBB.
Varma N; Manne M; Nguyen D; He J; Niebauer M; Tchou P
Heart Rhythm; 2014 Jul; 11(7):1139-47. PubMed ID: 24704570
[TBL] [Abstract][Full Text] [Related]
34. Clinical characteristics and prognosis of heart failure with mid-range ejection fraction: insights from a multi-centre registry study in China.
Lyu S; Yu L; Tan H; Liu S; Liu X; Guo X; Zhu J
BMC Cardiovasc Disord; 2019 Sep; 19(1):209. PubMed ID: 31477021
[TBL] [Abstract][Full Text] [Related]
35. Regional Variation of Mortality in Heart Failure With Reduced and Preserved Ejection Fraction Across Asia: Outcomes in the ASIAN-HF Registry.
MacDonald MR; Tay WT; Teng TK; Anand I; Ling LH; Yap J; Tromp J; Wander GS; Naik A; Ngarmukos T; Siswanto BB; Hung CL; Richards AM; Lam CSP; ;
J Am Heart Assoc; 2020 Jan; 9(1):e012199. PubMed ID: 31852421
[TBL] [Abstract][Full Text] [Related]
36. Association between systolic ejection time and outcomes in heart failure by ejection fraction.
Patel PA; Ambrosy AP; Phelan M; Alenezi F; Chiswell K; Van Dyke MK; Tomfohr J; Honarpour N; Velazquez EJ
Eur J Heart Fail; 2020 Jul; 22(7):1174-1182. PubMed ID: 31863532
[TBL] [Abstract][Full Text] [Related]
37. Prevalence, correlates, and prognostic significance of QRS prolongation in heart failure with reduced and preserved ejection fraction.
Lund LH; Jurga J; Edner M; Benson L; Dahlström U; Linde C; Alehagen U
Eur Heart J; 2013 Feb; 34(7):529-39. PubMed ID: 23041499
[TBL] [Abstract][Full Text] [Related]
38. Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD).
Tsuchihashi-Makaya M; Hamaguchi S; Kinugawa S; Yokota T; Goto D; Yokoshiki H; Kato N; Takeshita A; Tsutsui H;
Circ J; 2009 Oct; 73(10):1893-900. PubMed ID: 19644216
[TBL] [Abstract][Full Text] [Related]
39. Lp(a) [Lipoprotein(a)]-Related Risk of Heart Failure Is Evident in Whites but Not in Other Racial/Ethnic Groups.
Steffen BT; Duprez D; Bertoni AG; Guan W; Tsai MY
Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2498-2504. PubMed ID: 30354212
[TBL] [Abstract][Full Text] [Related]
40. Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum.
Lund LH; Claggett B; Liu J; Lam CS; Jhund PS; Rosano GM; Swedberg K; Yusuf S; Granger CB; Pfeffer MA; McMurray JJV; Solomon SD
Eur J Heart Fail; 2018 Aug; 20(8):1230-1239. PubMed ID: 29431256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
